Protagonist Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -8.76 | -100% |
| P/S |
|
21.04 | 33.77 | -37.69% |
|
|
| P/BV |
|
3.75 | 4.83 | -22.34% |
|
|
| P/FCF |
|
-15.81 | 61 | -125.92% |
|
|
| Ev/Ebitda |
|
-11.92 | -22.17 | -46.23% |
|
|
| Ev/S |
|
17.95 | 22.57 | -20.49% |
|
|
| Ev/FCF |
|
-15.2 | 68.76 | -122.1% |
|
|
| E/P |
|
-0.0705 | 0.0178 | -496.65% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-150.57 | 4.97 | -3128.25% | -6990.74 | -97.85% |
| ROE |
|
-23.45 | 9.61 | -343.99% |
|
|
| ROA |
|
-22.06 | 0.3443 | -6507.23% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-131.59 | -25.17 | 422.8% |
|
|
| ROCE |
|
-27.82 | 15.45 | -280.05% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0126 | -3.68 | -99.66% | -0.0226 | -44.17% |
| Nеt Debt/Ebitda |
|
2.05 | -3.44 | -159.77% |
|
|
| Debt/Ratio |
|
0.0032 | 0.1986 | -98.39% |
|
|
| Debt/Equity |
|
0.7131 | 1.66 | -57.1% |
|
|
| Debt/Net Income |
|
-0.0145 | 10.32 | -100.14% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
25874.03 | -57.64 | -44989.02% | ||
| Growth impulse Ebitda in 5 years |
|
16.25 | -90.94 | -117.87% | ||
| Growth impulse Net Income in 5 years |
|
2.29 | -97.8 | -102.34% | ||
| Growth impulse FCF in 5 years |
|
66.72 | -108.72 | -161.37% | ||
| Growth impulse EPS in 5 years |
|
-53.34 | -142.05 | -62.45% |
IP Score
3.36/10
